| Immunosenescence and inflammaging in the aging process: age-related diseases or longevity? A Santoro, E Bientinesi, D Monti Ageing research reviews 71, 101422, 2021 | 267 | 2021 |
| CXCR4 in human osteosarcoma malignant progression. The response of osteosarcoma cell lines to the fully human CXCR4 antibody MDX1338 S Pollino, E Palmerini, B Dozza, E Bientinesi, M Piccinni-Leopardi, ... Journal of bone oncology 17, 100239, 2019 | 20 | 2019 |
| Doxorubicin-induced senescence in normal fibroblasts promotes in vitro tumour cell growth and invasiveness: The role of Quercetin in modulating these processes E Bientinesi, M Lulli, M Becatti, S Ristori, F Margheri, D Monti Mechanisms of Ageing and Development 206, 111689, 2022 | 16 | 2022 |
| miR‑494.3 p expression in synovial sarcoma: Role of CXCR4 as a potential target gene L Pazzaglia, S Pollino, M Vitale, E Bientinesi, S Benini, C Ferrari, ... International Journal of Oncology 54 (1), 361-369, 2019 | 13 | 2019 |
| inflammaging in the aging process: Age-related diseases or longevity?., 2021, 71 A Santoro, E Bientinesi, DM Immunosenescence DOI: https://doi. org/10.1016/j. arr, 101422, 2021 | 5 | 2021 |
| Quercetin Induces Senolysis of Doxorubicin-Induced Senescent Fibroblasts by Reducing Autophagy, Preventing Their Pro-tumour Effect on Osteosarcoma Cells E Bientinesi, S Ristori, M Lulli, D Monti Mechanisms of Ageing and Development, 111957, 2024 | | 2024 |
| Therapy-induced senescence in normal fibroblasts promotes in vitro tumour cell growth and invasiveness: study of the role of Quercetin in modulating these processes. E Bientinesi, D Monti | | 2022 |
